EVOGENE LTD. AND ELEO INC. ANNOUNCE COLLABORATION TO DEVELOP NEXT-GENERATION ORAL SMALL-MOLECULE PCSK9 PATHWAY INHIBITORS FOR HYPERLIPIDEMIA AND CARDIOVASCULAR DISEASES

Reuters · 3d ago

Please log in to view news